Nutrition Profess Public Company Limited

Nutrition Profess Public Company Limited

4.68
THB
+0.06
(+1.30%)
0.39EPS
12.81P/E
589.62MMarket Cap
Nutrition Profess Public Company Limited
SET:NUT.R
(Stock Exchange of Thailand)

Recent

price

4.68

P/E

ratio

12.81

div

yld

11.11%

ROIC.AI

2022
2023
2024
2025
TTM
THB
- -
9.85
9.67
9.94
8.79
Revenue per Share
- -
0.54
0.46
0.56
0.39
Basic EPS, GAAP
- -
0.95
1.06
0.93
0.53
Free Cash Flow per Basic Share
- -
0.35
0.62
0.84
0.52
Dividend per Share
2.28
2.49
2.33
4.13
4.22
Book Value per Share
2.25
2.47
2.3
4.11
4.2
Tangible Book Value per Share
12
120
120
104
120
Basic Weighted Avg Shares
- -
1,183
1,161
1,032
1,055
Sales/Revenue/Turnover
- -
7.13
6.16
7.14
5.78
Operating Margin (%)
- -
42
44
44
45
Depreciation Expense
- -
65
55
58
47
Net Income, GAAP
- -
21.49
20.95
17.54
21.02
Effective Tax Rate (%)
- -
5.5
4.75
5.64
4.42
Profit Margin (%)
182
215
201
417
425
Working Capital
104
92
73
66
48
LT Debt
273
299
280
496
500
Total Equity
- -
16.12
14.21
12.6
8.15
Return on Invested Capital (%)
- -
17.28
15.28
13.07
8.68
Return on Capital (%)
- -
22.74
19.07
15.02
9.12
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
24
24
19
LT Borrowings
- -
- -
- -
LT Finance Leases
66
62
48
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
120
120
118
Market Capitalization
451
499
590

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
528
549
540
Cash, Cash Equivalents & STI
373
383
348
Accounts Receivable, Net
36
41
41
Inventories
101
105
112
Total Current Liabilities
111
112
115
Payables & Accruals
64
66
75
ST Debt
24
24
19
Deferred Revenue
17
19
17

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
77.18%
Free Cash Flow
- -
- -
-24.45%
Net Income, GAAP
- -
- -
5.53%
Sales/Revenue/Turnover
- -
- -
-11.07%
Total Cash Common Dividend
- -
- -
17.34%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
300
273
280
308
1,161
2025
290
239
245
258
1,032
2026
272
280
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.17
0.06
0.11
0.12
0.46
2025
0.24
0.16
0.07
0.05
0.56
2026
0.17
0.1
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.42
- -
0.21
- -
0.62
2025
0.38
- -
0.35
- -
0.84
2026
- -
0.17
- -
- -
- -
Business
Nutrition Profess Public Company Limited is a Thailand-based manufacturer and distributor of dietary supplements, functional foods, and cosmetic skincare products, operating primarily through original equipment manufacturer (OEM), original design manufacturer (ODM), and proprietary brand channels. Founded in 2017 and headquartered in Nonthaburi, Thailand, the company provides end-to-end product development, formulation, and contract manufacturing solutions for corporate clients, retail brand owners, and direct-to-consumer health markets. The company structures its operations across four primary product and service categories: dietary supplements, including capsules, tablets, softgels, effervescent formulations, and functional gummies for immune support, joint care, and metabolic health; functional food and beverage solutions, comprising instant powder beverage mixes, liquid botanical extracts, collagen drink sachets, and meal replacement shakes targeting weight management and detoxification; skincare and cosmeceutical formulations, encompassing anti-aging creams, brightening serums, facial cleansers, acne treatments, and UV protection lotions; and comprehensive OEM/ODM turnkey services, including custom laboratory research, active ingredient sourcing, stability testing, packaging development, and regulatory registration compliance with the Food and Drug Administration. In recent developments, Nutrition Profess Public Company Limited has executed several strategic growth and operational modernization initiatives, including preparations for capital market expansion on the Stock Exchange of Thailand under the ticker symbol NUT to fund facility upgrades and working capital. The company has expanded its manufacturing footprint with advanced automated production lines and certified cleanrooms; upgraded its proprietary research and development laboratory to develop standardized herbal extracts and probiotic nutraceuticals; entered into strategic supply chain and raw ingredient distribution partnerships across Southeast Asian regional markets; and broadened its commercial offerings with new functional health formulations and clinical-grade dermaceutical product lines.